Canon Medical’s AI-Powered, Premium Large Bore CT Receives FDA Clearance

Canon Medical Systems USA, Inc. has received FDA clearance for the Aquilion Exceed LB CT system, giving clinicians the opportunity to see more during radiation therapy planning for accuracy, precision and speed.

FDA Clears MULTIX Impact C Ceiling-Mounted DR System

Siemens Healthineers has announced the Food and Drug Administration (FDA) clearance of the MULTIX Impact C ceiling-mounted digital radiography (DR) system as well as the MULTIX Impact VA20, a new version of the established floor-mounted parent DR system.

FDA Approves Seno Medical’s Breast Cancer Diagnostic Technology

The Center for Devices and Radiological Health (CDRH) of the U.S. Food & Drug Administration (FDA) has granted Texas-based Seno Medical Instruments Inc.

Philips to Acquire Capsule Technologies Inc.

Royal Philips has signed an agreement to acquire Capsule Technologies Inc., a provider of medical device integration and data technologies for hospitals and healthcare organizations.

Lunit Expands Collaboration with GE Healthcare to Advance AI Adoption

Lunit recently announced the expansion of its collaboration with GE Healthcare. This collaboration between GE Healthcare and Lunit will help make AI algorithms more accessible to clinicians, alleviate clinical strain and streamline workflows – supporting better patient outcomes.

GE Healthcare recently introduced its Thoracic Care Suite featuring a collection of eight artificial intelligence (AI) algorithms from Lunit INSIGHT CXR[1]. The AI Suite quickly analyzes chest X-ray findings and flags abnormalities to radiologists for review, including pneumonia, which may be indicative of COVID-19 as well as tuberculosis, lung nodules, and other radiological findings.

This collaboration between GE Healthcare and Lunit is one of the first of its kind to bring commercially available AI products from a medical AI startup to an existing X-ray equipment manufacturer – making Lunit INSIGHT CXR available via Thoracic Care Suite to GE Healthcare’s thousands of global fixed, mobile, and R&F X-ray customers at point of sale.

“As a startup company, our vision is to have AI to be recognized as the new standard of care,” says Brandon Suh, CEO of Lunit. “We have been applying our AI into various types of medical images. Among them, Lunit INSIGHT CXR is one of our major products that has been commercialized since a few years ago. To have our AI made available with a market-leading vendor like GE Healthcare – especially as part of the Thoracic Care Suite – is a significant advancement in delivering solutions to various customers within GE Healthcare’s install base and bringing us all one step closer to embracing AI as a part of today’s standard of care. We will continue to push forward and cooperate with market leaders through extended partnerships and collaborations, increasing the number of global use cases of our AI.”

Lunit’s original algorithm, Lunit INSIGHT CXR, is designed to provide accurate and instant analysis of chest X-ray images by mapping the location of the findings and displaying the scored calculation of its actual existence. In a COVID-19 setting, Lunit INSIGHT CXR can be useful in quickly identifying high-risk cases as well as monitoring patients’ progression and regression of mild respiratory symptoms. The algorithm performs at 97-99% accuracy rate (Area Under the Curve – AUC), and according to studies published in Radiology[2] and JAMA Network Open[3], a physician can see their performance increase up to 20% upon interpreting with the assistance of Lunit’s AI.

“Like Lunit, GE Healthcare is committed to developing and providing AI solutions to help alleviate our customers’ most pressing challenges,” says Katelyn Nye, general manager of GE Healthcare mobile X-ray and AI products. “We’ve watched Lunit’s success closely over the past several years and are excited to marry our expertise as a well-established X-ray manufacturer with the nimbleness of a startup like Lunit. We believe that by featuring Lunit INSIGHT CXR as a part of our Thoracic Care Suite we can meet our customer’s most pressing needs and expand AI adoption in health care.”

Lunit is also actively working with GE Healthcare to integrate its AI solutions into GE’s Edison Open AI Orchestrator, an algorithm management solution to help physicians and health care organizations work more efficiently and effectively. Available via a standalone server or integrated into GE Healthcare’s Centricity Picture Archiving and Communication System (PACS) and Enterprise Imaging System (EIS), these algorithms can help clinicians manage chest radiography reading more efficiently, improve clinicians’ workflow and provide a more native reading experience. Once complete, this offering will help reduce the complexity of implementing and managing multiple systems and algorithms as well as provide an easy way for organizations to adopt and explore AI.

Additionally, Lunit is an innovator under GE Healthcare’s Edison Developer Program, which helps health care providers gain easier access to market-ready algorithms and applications – such as Lunit INSIGHT CXR – by directly integrating these technologies into existing workflows. As such, Lunit and GE Healthcare are actively working to deliver novel and targeted deep-learning technology for healthcare systems via Edison, GE Healthcare’s secure intelligence platform.

Lunit INSIGHT CXR is CE marked and is commercially available in European Economic Area and UK.

[1] Available in select CE Mark countries. Not available in all regions.

[2] SG Park et al., Development and Validation of Deep Learning–based Automatic Detection Algorithm for Malignant Pulmonary Nodules on Chest Radiographs

[3] EJ Hwang et al., Development and Validation of a Deep Learning–Based Automated Detection Algorithm for Major Thoracic Diseases on Chest Radiographs



Submit a Comment

Your email address will not be published. Required fields are marked *